Moderna withdraws doses of its vaccine in Japan due to “contamination”


Tokyo – Reuters

Moderna and Takeda Pharmaceuticals Inc said on Wednesday they are working with Japanese authorities to recall three batches of their COVID-19 vaccine after an investigation found stainless steel contaminants in some vials.
Last week, the Japanese authorities stopped using those batches of Moderna’s vaccine, which contained 1.63 million doses, after being notified of the contamination issue.
On Wednesday, the Japanese Ministry of Health said, based on information from investigations by the companies involved, that it does not believe that the stainless steel particles pose any additional health risks. Moderna said contamination with stainless steel may have occurred during production.
Moderna said in a joint statement with Makeda that the most likely cause of contamination is the friction between two pieces of metal in the machine that puts the stoppers on the flasks. It has been confirmed that the material is stainless steel.





These were the details of the news Moderna withdraws doses of its vaccine in Japan due to “contamination” for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Qatar sees 12-fold jump in surplus on energy profit
NEXT Etihad Rail welcomes first batch of National Rail Network fleet

Author Information

I have been an independent financial adviser for over 11 years in the city and in recent years turned my experience in finance and passion for journalism into a full time role. I perform analysis of Companies and publicize valuable information for shareholder community. Address: 2077 Sharon Lane Mishawaka, IN 46544, USA Phone: (+1) 574-255-1083 Email: [email protected]